Dr. Matt Birnholz welcomes Patrick Higgins, President and Chief Operating Officer of Tekmira Pharmaceuticals, to discuss his research team's inspiring journey toward developing a cure for Hepatitis C. Following this success, Tekmira aims to accelerate the pace of research and development for a novel Hepatitis B drug.